June 23, 2015Johnson & Johnson fined for Promoting Off-Label Use of Antipsychotic Medication for Nursing Home ResidentsJohnson & Johnson, a global pharmaceutical corporation, will pay more than $2.2 billion in civil and criminal penalties for, among other things, promoting the antipsychotic medication […]
